COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,871 Articles (22,568 medRxiv, 8,303 bioRxiv)

Most recent first Previous |  Page 1635: Articles 16341-16350  | Next

Using proper mean generation intervals in modelling of COVID-19
Tang, X., Musa, S. S., Zhao, S., He, D.
10.1101/2021.03.25.21254307 — Posted: 2021-03-26
Estimation of the Reproduction Number for COVID-19 Based on Latest Vaccination Results and the Timing for Herd-Immunity: Prospect for 2021
Zhu, S. S., Iboi, E.
10.1101/2021.03.25.21254362 — Posted: 2021-03-26
Mouth-rinses and SARS-CoV-2 viral load in saliva: A living systematic review
Hernandez Vasquez, A., Barrenechea Pulache, A., Comande, D., Azanedo, D.
10.1101/2021.03.23.21254214 — Posted: 2021-03-26
Vascular Comorbidities Worsen Prognosis of Patients with Heart Failure Hospitalized with COVID-19
Mok, J., Malpartida, J. C., O'Dell, K., Davis, J., Gao, C., Manyam, H.
10.1101/2021.03.23.21254209 — Posted: 2021-03-26
A differential regulatory T cell signature distinguishes the immune landscape of COVID-19 hospitalized patients from those hospitalized with other respiratory viral infections
Vick, S. C., Frutoso, M., Mair, F., Konecny, A. J., Greene, E., Wold, C. R., Logue, J., Boonyaratanakornkit, J., Gottardo, R., Schiffer, J. T., Chu, H. Y., Prlic, M., Lund, J. M.
10.1101/2021.03.25.21254376 — Posted: 2021-03-26
Shielding of Viruses such as SARS-CoV-2 from Ultraviolet Radiation in Particles Generated by Sneezing or Coughing: Numerical Simulations of Survival Fractions
Hill, S. C., Doughty, D. C., Mackowski, D. W.
10.1101/2021.03.23.21254172 — Posted: 2021-03-26
Optimizing SARS-CoV-2 Variant of Concern Screening: Experience from British Columbia, Canada, Early 2021
Hogan, C. A., Sbihi, H., Jassem, A., Prystajecky, N., Tyson, J. R., Lee, T. D., Tsang, F., Janz, L., Ng, C., Romney, M. G., Hoang, L.
10.1101/2021.03.23.21253520 — Posted: 2021-03-26
Expansion of Cytotoxic CD4+ T cells in the lungs in severe COVID-19
Kaneko, N., Boucau, J., Kuo, H.-h., Perugino, C., Mahajan, V., Farmer, J., Liu, H., Diefenbach, T., Piechocka-Trocha, A., Lefteri, K., Waring, M., Premo, K., Walker, B., Li, J. Z., Gaiha, G., Yu, X., Lichterfeld, M., Padera, R., Pillai, S.
10.1101/2021.03.23.21253885 — Posted: 2021-03-26
Tocilizumab in hospitalized COVID-19 patients: A meta-analysis of randomized controlled trials
Selvaraj, V., Saud Khan, M., Bavishi, C., Dapaah-Afriyie, K., Finn, A., Lal, A., Mylonakis, E.
10.1101/2021.03.23.21254054 — Posted: 2021-03-26
Droplet Digital RT-PCR to detect SARS-CoV-2 variants of concern in wastewater.
Heijnen, L., Elsinga, G., de Graaf, M., Molenkamp, R., Koopmans, M. P. G., Medema, G.
10.1101/2021.03.25.21254324 — Posted: 2021-03-26

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).